Logo image of GRPN

GROUPON INC (GRPN) Stock Fundamental Analysis

NASDAQ:GRPN - Nasdaq - US3994732069 - Common Stock - Currency: USD

33.89  +1.56 (+4.83%)

Premarket: 34.5 +0.61 (+1.8%)

Fundamental Rating

2

Taking everything into account, GRPN scores 2 out of 10 in our fundamental rating. GRPN was compared to 28 industry peers in the Broadline Retail industry. GRPN may be in some trouble as it scores bad on both profitability and health. GRPN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year GRPN has reported negative net income.
GRPN had a positive operating cash flow in the past year.
GRPN had negative earnings in 4 of the past 5 years.
GRPN had negative operating cash flow in 4 of the past 5 years.
GRPN Yearly Net Income VS EBIT VS OCF VS FCFGRPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

GRPN has a worse Return On Assets (-6.51%) than 67.86% of its industry peers.
GRPN's Return On Equity of -87.03% is on the low side compared to the rest of the industry. GRPN is outperformed by 78.57% of its industry peers.
Industry RankSector Rank
ROA -6.51%
ROE -87.03%
ROIC N/A
ROA(3y)-16.43%
ROA(5y)-11.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRPN Yearly ROA, ROE, ROICGRPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

GRPN's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 90.42%, GRPN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of GRPN has grown nicely.
The Profit Margin and Operating Margin are not available for GRPN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.42%
OM growth 3Y-37.22%
OM growth 5Y-11.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.78%
GM growth 5Y11.03%
GRPN Yearly Profit, Operating, Gross MarginsGRPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

GRPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GRPN has more shares outstanding
GRPN has more shares outstanding than it did 5 years ago.
GRPN has a better debt/assets ratio than last year.
GRPN Yearly Shares OutstandingGRPN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GRPN Yearly Total Debt VS Total AssetsGRPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

GRPN has an Altman-Z score of -1.30. This is a bad value and indicates that GRPN is not financially healthy and even has some risk of bankruptcy.
GRPN has a worse Altman-Z score (-1.30) than 67.86% of its industry peers.
The Debt to FCF ratio of GRPN is 4.89, which is a neutral value as it means it would take GRPN, 4.89 years of fcf income to pay off all of its debts.
GRPN's Debt to FCF ratio of 4.89 is in line compared to the rest of the industry. GRPN outperforms 53.57% of its industry peers.
A Debt/Equity ratio of 4.24 is on the high side and indicates that GRPN has dependencies on debt financing.
With a Debt to Equity ratio value of 4.24, GRPN is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.24
Debt/FCF 4.89
Altman-Z -1.3
ROIC/WACCN/A
WACC8.78%
GRPN Yearly LT Debt VS Equity VS FCFGRPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.89 indicates that GRPN may have some problems paying its short term obligations.
With a Current ratio value of 0.89, GRPN is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
A Quick Ratio of 0.89 indicates that GRPN may have some problems paying its short term obligations.
The Quick ratio of GRPN (0.89) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.89
GRPN Yearly Current Assets VS Current LiabilitesGRPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

GRPN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -184.00%.
GRPN shows a decrease in Revenue. In the last year, the revenue decreased by -5.76%.
The Revenue for GRPN have been decreasing by -25.99% on average. This is quite bad
EPS 1Y (TTM)-184%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%154.55%
Revenue 1Y (TTM)-5.76%
Revenue growth 3Y-20.14%
Revenue growth 5Y-25.99%
Sales Q2Q%-4.79%

3.2 Future

GRPN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.81% yearly.
Based on estimates for the next years, GRPN will show a small growth in Revenue. The Revenue will grow by 7.91% on average per year.
EPS Next Y140.41%
EPS Next 2Y56.17%
EPS Next 3Y43.81%
EPS Next 5YN/A
Revenue Next Year2%
Revenue Next 2Y5.03%
Revenue Next 3Y6.78%
Revenue Next 5Y7.91%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GRPN Yearly Revenue VS EstimatesGRPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
GRPN Yearly EPS VS EstimatesGRPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GRPN. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 63.29, GRPN can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GRPN indicates a slightly more expensive valuation: GRPN is more expensive than 71.43% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.13. GRPN is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 63.29
GRPN Price Earnings VS Forward Price EarningsGRPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

GRPN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. GRPN is more expensive than 67.86% of the companies in the same industry.
GRPN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 26.79
EV/EBITDA 52.25
GRPN Per share dataGRPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

GRPN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GRPN's earnings are expected to grow with 43.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.17%
EPS Next 3Y43.81%

More info and screens

0

5. Dividend

5.1 Amount

GRPN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GROUPON INC

NASDAQ:GRPN (6/13/2025, 8:05:34 PM)

Premarket: 34.5 +0.61 (+1.8%)

33.89

+1.56 (+4.83%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-28 2025-07-28
Inst Owners57.85%
Inst Owner Change6.28%
Ins Owners2.25%
Ins Owner Change0.3%
Market Cap1.35B
Analysts78
Price Target23.21 (-31.51%)
Short Float %31.11%
Short Ratio4.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1287.87%
Min EPS beat(2)-2841.18%
Max EPS beat(2)265.44%
EPS beat(4)2
Avg EPS beat(4)-621.39%
Min EPS beat(4)-2841.18%
Max EPS beat(4)302.21%
EPS beat(8)4
Avg EPS beat(8)-404.39%
EPS beat(12)7
Avg EPS beat(12)-264.94%
EPS beat(16)9
Avg EPS beat(16)-99.17%
Revenue beat(2)1
Avg Revenue beat(2)-0.23%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)0.06%
Revenue beat(4)2
Avg Revenue beat(4)-1.23%
Min Revenue beat(4)-4.79%
Max Revenue beat(4)0.36%
Revenue beat(8)4
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-3.39%
Revenue beat(16)5
Avg Revenue beat(16)-2.88%
PT rev (1m)22.97%
PT rev (3m)51.67%
EPS NQ rev (1m)-649.77%
EPS NQ rev (3m)43.58%
EPS NY rev (1m)0%
EPS NY rev (3m)360.31%
Revenue NQ rev (1m)1.55%
Revenue NQ rev (3m)3.25%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 63.29
P/S 2.77
P/FCF 26.79
P/OCF 20.45
P/B 29.67
P/tB N/A
EV/EBITDA 52.25
EPS(TTM)-0.71
EYN/A
EPS(NY)0.54
Fwd EY1.58%
FCF(TTM)1.26
FCFY3.73%
OCF(TTM)1.66
OCFY4.89%
SpS12.22
BVpS1.14
TBVpS-3.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.51%
ROE -87.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.42%
FCFM 10.35%
ROA(3y)-16.43%
ROA(5y)-11.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-37.22%
OM growth 5Y-11.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.78%
GM growth 5Y11.03%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 4.24
Debt/FCF 4.89
Debt/EBITDA 7.37
Cap/Depr 58.2%
Cap/Sales 3.21%
Interest Coverage N/A
Cash Conversion 251.8%
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.89
Altman-Z -1.3
F-Score5
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)52%
Cap/Depr(5y)57.82%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-184%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%154.55%
EPS Next Y140.41%
EPS Next 2Y56.17%
EPS Next 3Y43.81%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.76%
Revenue growth 3Y-20.14%
Revenue growth 5Y-25.99%
Sales Q2Q%-4.79%
Revenue Next Year2%
Revenue Next 2Y5.03%
Revenue Next 3Y6.78%
Revenue Next 5Y7.91%
EBIT growth 1Y-103.33%
EBIT growth 3Y-49.87%
EBIT growth 5Y-34.77%
EBIT Next Year906.01%
EBIT Next 3Y156.79%
EBIT Next 5Y96.85%
FCF growth 1Y129.78%
FCF growth 3YN/A
FCF growth 5Y188.49%
OCF growth 1Y149.2%
OCF growth 3YN/A
OCF growth 5Y-4.75%